Noreen Griffin

Immune Therapeutics, Inc. – June 30, 2016 (December 1st, 2016)

Reference is made to that certain Services Agreement (the "Agreement") dated December 15, 2014 between Aronstam Management Services Inc., a Florida corporation represented by you, its President ("Contractor"), and Immune Therapeutics, Inc., a Florida corporation ("Company").

Immune Therapeutics, Inc. – Addendum to Common Stock Purchase Warrant Document W-04122016 (December 1st, 2016)

This Addendum dated April 12, 2016 between Immune Therapeutics, Inc. (the "Company" or the "Issuer") and JMJ Financial (the "Holder" or the "Investor") supplements and applies to the Common Stock Purchase Warrant Document W-04062016 between the Issuer and the Investor.

Immune Therapeutics, Inc. – Contract for the Manufacturing of Pharmaceutical Products (November 15th, 2016)

Immune Therapeutics, Inc. registered under the laws of the State of Florida, United States of America, and incorporated under P3000082736Twrth its corporate domicile and main office at 37 N Orange Ave 607, Orlando Florida and represented by Noreen Griffin, Chief Executive Officer, with her Passport No.496803653.

Immune Therapeutics, Inc. – Addendum to Common Stock Purchase Warrant Document W-04122016 (November 10th, 2016)

This Addendum dated April 12, 2016 between Immune Therapeutics, Inc. (the "Company" or the "Issuer") and JMJ Financial (the "Holder" or the "Investor") supplements and applies to the Common Stock Purchase Warrant Document W-04062016 between the Issuer and the Investor.

Immune Therapeutics, Inc. – June 30, 2016 (November 10th, 2016)

Reference is made to that certain Services Agreement (the "Agreement") dated December 15, 2014 between Aronstam Management Services Inc., a Florida corporation represented by you, its President ("Contractor"), and Immune Therapeutics, Inc., a Florida corporation ("Company").

Immune Therapeutics, Inc. – Contract for the Compounding of Pharmaceutical Products (May 20th, 2016)

This CONTRACT FOR THE COMPOUNDING OF PHARMACEUTICAL PRODUCTS (this "Agreement") is hereby entered into this 16th day of May, 2016, by and between Immune Therapeutics, Inc., a corporation organized and currently existing in good standing under the laws of the State of Florida ("IMUN"), and Complete Pharmacy and Medical Solutions, LLC, a limited liability company also known as Complete Pharmaceutics and organized and currently existing in good standing under the laws of the State of Florida ("CPMS"). IMUN and CPMS are sometimes hereinafter referred to individually as a "party" and/or collectively as the "parties".